Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 3 hours ago
BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions
about 3 hours ago
Recorded at Fierce Biotech Week in Boston, this episode of “The Top...
Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both
about 5 hours ago
It’s been more than four years since Novartis shook up the CAR-T...
OSE turns up the heat on ovarian cancer with phase 2, Keytruda-supported win
about 6 hours ago
OSE Immunotherapeutics has shared phase 2 data on its neo-epitope vaccine candidate...
Biogen axes Denali-partnered Parkinson’s prospect after phase 2 flop
about 7 hours ago
A phase 2b trial of Biogen and Denali Therapeutics’ Parkinson’s disease candidate...
Chutes & Ladders—Former FDA leader takes new biotech Turn
about 20 hours ago
Stephen Hahn, M.D., who served as the commissioner of the FDA for...
ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
about 20 hours ago
According to an abstract released ahead of the ASCO 2026 annual meeting...
Medtronic inks $650M deal for SPR Therapeutics
1 day ago
Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company...
Betting on biotech: Prediction markets set sights on clinical trials
1 day ago
Several biotech contracts are rotating through Kalshi and Polymarket, while a recently...
Lilly’s triple-G drug helps patients lose roughly a quarter of weight, showcasing competitive profile
1 day ago
As Eli Lilly looks to hold its lead in the lucrative obesity...
Struggling Liminatus pays $320M in stock for CAR-T biotech InnocsAI
1 day ago
Cancer immunotherapy company Liminatus Pharma has agreed to pay out shares worth...
Infex, following in Insmed’s footsteps, advances lung disease candidate after clearing phase 2a
1 day ago
Infex Therapeutics is pushing ahead with development of a non-cystic fibrosis bronchiectasis...
US taps small San Diego biotech for experimental Ebola treatment as epidemic worsens
1 day ago
As an outbreak of Ebola in central Africa continues to worsen, the...